Viecuri logo

dr. R.P.R. (Rob) Adang

MDL-arts

Specialisme

Oncologie Hepatitis behandelcentrum Maag-Darm-Leverziekten (MDL)

BIG-nummer

19019641701

Aandachtsgebieden

  •  Inflammatoire darmziekten (colitis ulcerosa en morbus Crohn)

  •  Colorectale adenomen / carcinomen (darmpoliepen en darmkanker)

  •  Bevolkingsonderzoek darmkanker

  •  Therapeutische endoscopie

Opleidingen

  • Studie Geneeskunde aan Rijksuniversiteit Utrecht  
  • Opleiding tot internist en MDL-arts aan Maastricht Universitair Medisch Centrum

Specialist sinds

1998 

In VieCuri sinds

1998 

Talen

Nederlands, Engels en Duits

Andere activiteiten

  • Orde van Medisch Specialisten (OMS)
  • Nederlandse Vereniging van MDL-artsen (NVMDL)
  • Nederlandse Vereniging voor Gastro-enterologie (NVGE)
  • European Crohn's and Colitis Organisation (ECCO)

  • Regionaal Coördinerend MDL-arts (RCMDL) voor Bevolkingsonderzoek Zuid, Maastricht-Eindhoven (2013-2016)

Biografie

Rob Adang studeerde geneeskunde aan de Rijksuniversiteit Utrecht en is opgeleid tot internist en vervolgens tot MDL-arts in het Maastricht Universitair Medisch Centrum. Sinds augustus 1998 is hij - als eerste MDL-arts - werkzaam in VieCuri Medisch Centrum. Hij is een ervaren allround MDL-arts met als aandachtsgebieden inflammatoire darmziekten (morbus Crohn en colitis ulcerosa), colorectale maligniteiten (darmkanker) en endoscopische interventies. Van maart 2013 tot oktober 2016 was hij ook werkzaam als Regionaal Coördinerend MDL-arts (RCMDL) voor Bevolkingsonderzoek Zuid en was in deze functie nauw betrokken bij de organisatie van het bevolkingsonderzoek darmkanker in de regio Zuid (Limburg en Brabant).

Rob Adang is gehuwd, heeft 4 kinderen, zijn hobby's zijn hardlopen, golf, fotografie, architectuur en Spaans.

Onderzoek en publicaties

  • Promotie aan de Faculteit der Geneeskunde van de Rijksuniversiteit Limburg, proefschrift: The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic diagnoses.

    Adang RPR, Breed WPM. Leverbeschadiging tijdens gebruik van busulfan. Ned Tijdschr Geneeskd 1989; 30: 1515-1518.

  • Vismans F-JFE, Adang RPR. De waarde van de anamnese bij dyspepsie. Medifo 1989; 5: 4-10.

  • Adang RPR, Vismans F-JFE, Schijven R, Talmon J, Ambergen A. The predictive value of age, sex and short medical history for upper gastrointestinal disease. Neth J Med 1989; 35: A53.

  • Adang RPR, Vismans F-JFE. Ulcers and nonsteroidal anti-inflammatory drugs: an epidemiologic study. In: Proceedings Holland Digestive Disease Week. Amsterdam, 1989: 275.

  • Adang RPR, F-JFE Vismans, Flendrig JA, Schijven RAJ, Talmon JL, Ambergen AW, Hasman A. Development of a decision support system for upper and lower gastrointestinal disease. In: Proceedings Second World Congress on Efficiency and Economy in Health Care. Maastricht, 1990.

  • Adang RP, Flendrig JA, Vismans F-JFE. The clinical presentation of NSAID-associated ulcers versus peptic ulcers. Neth J Med 1990: 37; A60.

  • Adang RP, Vismans F-JFE, Ambergen AW, Talmon JL, Hasman A, Flendrig JA. Predicting upper gastrointestinal endoscopic findings. Eur J Clin Inves 1990; 20: A51.

  • Talmon JL, Franssen MAIM, Adang RP. A computer system for the interrogation of patients. Eur J Clin Inves 1990; 20: A50.

  • Adang RP, Vismans F-JFE, Ambergen AW, Talmon JL, Hasman A, Flendrig JA. Evaluation of computerised questionnaires designed for patients referred for gastrointestinal endoscopy.Int J Biomed Comp 1991; 29: 31-44.

  • Adang RP, Schouten HC, van Tiel FH, Blijham GH. Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia 1992; 6: 224-226.

  • Adang RP, Loffeld RJLF. The differences between bleeding and non-bleeding duodenal ulcers (DU): a comparison of clinical data. Neth J Med 1992; 40: A15.

  • Adang RP, Stockbrügger RW, Vismans F-JFE, Ambergen AW, Talmon JL, Hasman A. Discriminative value of history data with regard to upper gastrointestinal endoscopic findings. Eur J Clin Inves 1993; 23 suppl 1: A19.

  • Adang RP, Manus B, Ambergen AW, Brägelmann R, Armbrecht U, Stockbrügger RW. Risk factors for rectosigmoid adenomas: a prospective screening study of 665 subjects. Neth J Med 1993; 43: A14-15.

  • Hameeteman W, Adang RP. Epidemiologie van peptische aandoeningen. Diagnose Informatie en Medische Statistiek 1994; 17: 4-7.

  • Adang RP, Vismans F-JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW. The diagnostic outcome of upper gastrointestinal endoscopy: are referral source and patient age determining factors?  Eur J Gastroenterol Hepatol 1994; 6: 329-335.

  • Adang RP, Vismans F-JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW. Are relevant upper gastrointestinal endoscopic findings predictable? Gastroenterology 1994; 106 suppl: A1.

  • Adang RP, Vismans F-JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW. Referral source and patient age as determinants for upper endoscopic diagnoses. Gastroenterology 1994; 106 suppl: A2.

  • Stockbrügger RW, Adang RP, Manus B, Ambergen AW, Brägelmann R, Armbrecht U. Risk factor profile for rectosigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation center. Gastroenterology 1994; 106 suppl: A443.

  • Manus B, Adang RP, Ambergen AW, Brägelmann R, Armbrecht U, Stockbrügger RW. Risk factors for rectosigmoid adenomas: a prospective study of 665 subjects. Z Gastroente­rol 1994; 32 suppl 1: 61.

  • Adang RP, Vismans F-JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastrointest Endosc 1995; 42: 390-397.

  • Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans F-JFE, Stockbrügger RW. The discriminatory value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings. Neth J Med 1995; 46: A18-19.

  • Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans F-JFE, Stockbrügger RW. The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1147 patients. Digestion 1996; 57: 118-134.

  • Adang RP. Dyspepsie en peptische aandoeningen. Diagnose Informatie en Medische Statistiek 1996; 20: 4-8.

  • Adang RP. Ultrasonographic assessment of portal hypertension. In: Cooreman MPR, Jansen JBMJ, editors. Diagnosis of chronic hepatic diseases - New developments. Nijmegen: PAOG-Heyendael. 1996: 27-50.

  • Manus B, Adang RP, Ambergen AW, Brägelmann R, Armbrecht U, Stockbrügger RW. The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prevent 1997; 6: 38-43.

  • de Ridder RJ, Arends JW, Stockbrügger RW, Adang RP. Histomorphometric assessment of fibrosis in advanced alcoholic liver disease. Eur J Gastroenterol Hepatol 1997; 9: A11.

  • Adang RP, Hameeteman W, Stockbrügger RW. Endoscopic transmural drainage of pancreatic pseudocysts using a linear array type echoendoscope: a description of different techniques in two patients. Eur J Gastroenterol Hepatol 1997; 9: A26.

  • Wensing JWM, Stockbrügger RW, Adang RP. Ursodeoxycholic acid in alcoholic liver disease. Br Med J 1997; 11: 588X-XI.

  • Adang RP, Wensing JWM, Stockbrügger RW. Alcohol consumption and alcohol-related liver disease in The Netherlands. Scand J Gastroenterol 1998; 33 suppl 225: 70-74.

  • Adang RP. Helicobacter pylori-like dyspepsia: fact or myth? Neth J Med 1998; 53: 147-152.

  • Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-2368.

  • Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49: 720-724.

  • Janssen MJR, Fransen GAJ, Voutilainen M, Adang RPR, Sung JJY, Numans ME, Thomson ABR, Manes G, Hammer J, Boldys H, Laheij RJF, Jansen JBMJ. Alarm symptoms for gastro-oesophageal malignancy: a meta-analysis using individual data. In: Janssen MJR. Dyspepsia et al. [Thesis] 2007.

  • Janssen MJR, Fransen GAJ, Voutilainen M, Adang RPR, Sung JJY, Numans ME, Thomson ABR, Manes G, Hammer J, Boldys H, Laheij RJF, Jansen JBMJ. Alarm symptoms for gastro-oesophageal malignancy: a meta-analysis using individual data. In: Fransen GAJ. Dyspepsia in primary care: patient expectations, symptoms, and treatment adherence. [Thesis] 2007.

  • van Leusen R, Adang RP, de Vries RA, Cnossen TT, Konings CJ, Schalm SW, Tan AC. Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2008; 23: 721-725.

  • Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR; Dutch PBC Study Group. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 2009; 136: 1281-1287.

  • van Hove A, Adang RP, van Kuijk WH. Unexplained iron-deficiency due to Helicobacter pylori. Ned Tijdschr Geneeskd 2009; 153: B350.

  • van den Kerkhof M, van Neerven A, Friederich P, Ocran K, Wolters F, Adang RPR. Nurse endoscopists doing colonoscopy: a prospective study on performance in clinical practice of a general hospital. Nederlandse Vereniging voor Gastro-enterologie; Najaarscongres 2009.

  • Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51: 210-218.

  • Kuiper EM, Hansen BE, Adang RP, van Nieuwkerk CM, Timmer R, Drenth JP, Spoelstra P, Brouwer HT, Kuyvenhoven JP, van Buuren HR; Dutch PBC Study Group. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. Eur J Gastroenterol Hepatol 2010; 22: 1495-1502.

  • van Putten PG, Ter Borg F, Adang RP, Van Leerdam ME, Kuipers EJ. Nurse endoscopists performing colonoscopy: A prospective study on quality and patient experiences. Gastrointest Endosc 2010; 71: AB130.

  • van Putten PG, Ter Borg F, Adang RP, Koornstra JJ, Romberg-Camps MJ, Timmer R, Poen AC, Kuipers EJ, Van Leerdam ME. Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy 2012; 44: 1127-1132.

scroll terug naar boven